Home > Healthcare > Medical Devices > Diagnostic Devices > Magnetoencephalography Market
The global magnetoencephalography market was valued at USD 223.5 million in 2023 and is expected to exhibit growth at a CAGR of 11.1% from 2024 to 2032. The market is propelled by advancements in neuroscience and a rising demand for precise, non-invasive brain imaging solutions.
One of the major drivers is the increasing prevalence of neurological disorders, such as epilepsy, Alzheimer’s, and Parkinson’s disease, which require accurate diagnostics for effective management. MEG provides a powerful tool for mapping brain activity with high temporal resolution, enabling clinicians to detect abnormal brain function in real-time, which is particularly beneficial in epilepsy diagnosis and surgical planning.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Magnetoencephalography Market Size in 2023: | USD 223.5 Million |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 11.1% |
2024 – 2032 Value Projection: | USD 591.6 Million |
Historical Data for: | 2021-2023 |
No. of Pages: | 130 |
Tables, Charts & Figures: | 100 |
Segments covered: | Product Type, Application, End Use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The growing use of MEG in research and clinical applications also fuels market expansion. MEG’s ability to map brain activity non-invasively makes it invaluable for neuroscience research, cognitive studies, and clinical applications, especially in understanding sensory processing, language, and motor functions. Increasing investments in neuroscience research by both governments and private sectors contribute to market growth as well.
Technological advancements, such as the development of portable and hybrid MEG systems, enhance accessibility and usability, opening up new possibilities for clinical and research use in various settings. Innovations in data analysis and machine learning further support the use of MEG by enabling sophisticated interpretations of MEG data, which can aid in early diagnosis and personalized treatment planning.
Additionally, rising awareness and adoption of MEG in emerging economies contribute to market growth as healthcare facilities in these regions expand their diagnostic capabilities. Collaborations among healthcare institutions, research bodies, and medical device companies to develop and improve MEG technology also drive advancements in this field.
Magnetoencephalography (MEG) is a non-invasive medical imaging technique used to measure the magnetic fields produced by neural activity in the brain. This process captures real-time brain function with high temporal resolution, enabling precise mapping of brain regions involved in various cognitive tasks. MEG is commonly used in both research and clinical settings, aiding in the diagnosis and management of neurological disorders like epilepsy, where identifying the exact source of abnormal brain activity is crucial. Due to its accuracy and minimal invasiveness, MEG is an invaluable tool for studying brain dynamics and planning surgical interventions.